ALPHA News

Press Release: Alpha FMC Hires New North America Partner, Adding Additional Senior Industry Expertise

Dow JonesDec 16 09:30 ET

ALPHA To Go Ex-Dividend On December 17th, 2024 With 0.005 MYR Dividend Per Share

Moomoo NewsDec 15 20:00 ET

Alpha Modus Shares to Begin Trading on Nasdaq Dec. 16

WSJDec 13 17:53 ET

Press Release: Alpha Modus and Insight Acquisition Corp Close Business Combination and Alpha Modus Will Begin Trading Under "AMOD" Ticker

Dow JonesDec 13 17:10 ET

One Bio Secures $27 Million in Series A Funding to Revolutionize Nutrition With Launch of Breakthrough Technology Making High-Dose, Anti-Inflammatory Plant Fiber Imperceptible in Food and Beverage for the First Time

PR NewswireDec 13 15:28 ET

Immutep's Eftilagimod Alpha Shows Promising Results in Head and Neck Cancer Study, Justifying Buy Rating

TipRanksDec 13 14:05 ET · Ratings

Express News | Alpha Cognition Announces Voluntary Delisting From CSE

ReutersDec 12 18:41 ET

Targeted Alpha Therapy Market 2028

GlobeNewswireDec 12 12:55 ET

Alpha, a New AI Watchlist App, Launches to Give Individual Investors Real-Time Insights On The Markets

PR NewswireDec 12 09:00 ET

Krystal Biotech Announces Promising Clinical Data for KB408 Gene Therapy in Alpha-1 Antitrypsin Deficiency Patients and Progress on KB407 for Cystic Fibrosis

Quiver QuantitativeDec 12 08:13 ET

TD Cowen Reaffirms Their Buy Rating on Alpha Teknova (TKNO)

TipRanksDec 12 07:26 ET · Ratings

Alpha Growth Strengthens Board With New Non-Executive Director Appointment

TipRanksDec 12 06:07 ET

Alpha HPA Advances Commercialization Initiatives for Synthetic Sapphire Unit; Shares Down 5%

MT NewswiresDec 11 23:17 ET

Alpha HPA Target Price Raised 2.1% to A$1.43/Share by Macquarie>A4N.AU

Dow JonesDec 11 17:55 ET

Alpha Announces "Positive" Interim Pre-Clinical Data For Repetitive Mild Traumatic Brain Injury Study

MT NewswiresDec 11 09:02 ET

HighVista Strategies Marks 20 Years of Pursuing Alpha in Alternative Investments

BusinesswireDec 11 09:00 ET

Express News | Alpha Cognition Announces Interim Interim Pre-Clinical Data For ALPHA-1062 Providing Evidence Of Benefit In Treatment Of MTBI Resulting From Blast Trauma

BenzingaDec 11 08:41 ET

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 11 08:30 ET

Astria Therapeutics Announces Final Results From ALPHA-STAR Trial

TipRanksDec 11 08:10 ET

Express News | Astria Therapeutics Reports Final Results From ALPHA-STAR Phase 1b/2 Trial Of Navenibart For HAE; 90-95% Attack Rate Reduction With 67% Attack-Free Rate Over 6 Months; Phase 3 Trial To Begin Q1 2025 With Topline Results Expected By Year-End 2026

BenzingaDec 11 08:07 ET